Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|April 4, 2022
Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung CancerZhiwen Fu, Shijun Li, Jinmei Liu, et al.
Frontiers in Pharmacology|April 10, 2025
QingGan LiDan capsules improved alcoholic liver injury by regulating liver lipid transport and oxidative stress in miceZhiwen Fu, Jiafeng Zhou, Hongye Pan, et al.
Cancer Biology & Medicine|April 7, 2026
Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectivesYajing Liu, Yuwei Liu, Tingting Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 6, 2026
Light-Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect ReconstructionTingting Wu, Yajing Liu, Shuman Wang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 24, 2016
The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFCFei Guo, Bing Zhang, Zhiwen Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 21, 2026
Factors associated with cancer pain management behavior among pharmacists: a cross-sectional study based on the COM-B modelCong Zhang, Shijun Li, Jinmei Liu, et al.
Inflammopharmacology|October 4, 2025
Kaempferol prevents Nrf2 from ubiquitin-mediated proteolysis to mitigate both NLRP3 inflammation and oxidative stress: implications for alleviating DSS-induced colitis in miceWentian Hua, Minrui Li, Ziwei Yan, et al.
Acta Pharmaceutica Sinica. B|July 10, 2023
Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutationsChen Shi, Cong Zhang, Zhiwen Fu, et al.
Pharmacological Research|January 31, 2024
Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathwayChen Shi, Cong Wang, Zhiwen Fu, et al.
Molecular Cancer|October 1, 2024
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discoveryJunyu Wu, Guoyi Tang, Chien-Shan Cheng, et al.
Pageof 5